Carbidopa/levodopa controlled-release - Depomed

Drug Profile

Carbidopa/levodopa controlled-release - Depomed

Alternative Names: DM-1992

Latest Information Update: 09 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Depomed
  • Class Antiparkinsonians; Aromatic amino acids; Catecholamines; Hydrazines; Small molecules
  • Mechanism of Action Decarboxylase inhibitors; Dopamine receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Suspended Parkinson's disease

Most Recent Events

  • 13 Nov 2012 Depomed completes a phase II trial in Parkinson's disease in the USA (NCT01515410)
  • 09 Nov 2012 Interim efficacy and safety data from a phase II trial in Parkinson's disease released by Depomed
  • 05 Jul 2012 Depomed completes enrolment in its phase II trial in Parkinson's disease in the US (NCT01515410)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top